We extended this by demonstrating that miR-206 has a similar growth inhibitory effect on both the in vitro and in vivo proliferation of breast cancer cells, but only when they express high levels of Myc as would be expected of a classic synthetic lethal relationship (Figure 3) [21–25]. Here, MYC is linked to breast carcinoma.